Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $54,995 - $61,493
950 Added 20.99%
5,476 $318 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $43,004 - $47,749
-675 Reduced 12.98%
4,526 $289 Million
Q1 2023

Apr 13, 2023

SELL
$65.71 - $74.53 $12,484 - $14,160
-190 Reduced 3.52%
5,201 $360 Million
Q4 2022

Apr 05, 2023

BUY
$68.48 - $81.09 $369,175 - $437,156
5,391 New
5,391 $388 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Eaton Financial Holdings Company, LLC Portfolio

Follow Eaton Financial Holdings Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Financial Holdings Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Financial Holdings Company, LLC with notifications on news.